CO7A1_HUMAN - dbPTM
CO7A1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CO7A1_HUMAN
UniProt AC Q02388
Protein Name Collagen alpha-1(VII) chain
Gene Name COL7A1
Organism Homo sapiens (Human).
Sequence Length 2944
Subcellular Localization Secreted, extracellular space, extracellular matrix, basement membrane.
Protein Description Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen..
Protein Sequence MTLRLLVAALCAGILAEAPRVRAQHRERVTCTRLYAADIVFLLDGSSSIGRSNFREVRSFLEGLVLPFSGAASAQGVRFATVQYSDDPRTEFGLDALGSGGDVIRAIRELSYKGGNTRTGAAILHVADHVFLPQLARPGVPKVCILITDGKSQDLVDTAAQRLKGQGVKLFAVGIKNADPEELKRVASQPTSDFFFFVNDFSILRTLLPLVSRRVCTTAGGVPVTRPPDDSTSAPRDLVLSEPSSQSLRVQWTAASGPVTGYKVQYTPLTGLGQPLPSERQEVNVPAGETSVRLRGLRPLTEYQVTVIALYANSIGEAVSGTARTTALEGPELTIQNTTAHSLLVAWRSVPGATGYRVTWRVLSGGPTQQQELGPGQGSVLLRDLEPGTDYEVTVSTLFGRSVGPATSLMARTDASVEQTLRPVILGPTSILLSWNLVPEARGYRLEWRRETGLEPPQKVVLPSDVTRYQLDGLQPGTEYRLTLYTLLEGHEVATPATVVPTGPELPVSPVTDLQATELPGQRVRVSWSPVPGATQYRIIVRSTQGVERTLVLPGSQTAFDLDDVQAGLSYTVRVSARVGPREGSASVLTVRREPETPLAVPGLRVVVSDATRVRVAWGPVPGASGFRISWSTGSGPESSQTLPPDSTATDITGLQPGTTYQVAVSVLRGREEGPAAVIVARTDPLGPVRTVHVTQASSSSVTITWTRVPGATGYRVSWHSAHGPEKSQLVSGEATVAELDGLEPDTEYTVHVRAHVAGVDGPPASVVVRTAPEPVGRVSRLQILNASSDVLRITWVGVTGATAYRLAWGRSEGGPMRHQILPGNTDSAEIRGLEGGVSYSVRVTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQRGEHSLRLRWEPVPRAQGFLLHWQPEGGQEQSRVLGPELSSYHLDGLEPATQYRVRLSVLGPAGEGPSAEVTARTESPRVPSIELRVVDTSIDSVTLAWTPVSRASSYILSWRPLRGPGQEVPGSPQTLPGISSSQRVTGLEPGVSYIFSLTPVLDGVRGPEASVTQTPVCPRGLADVVFLPHATQDNAHRAEATRRVLERLVLALGPLGPQAVQVGLLSYSHRPSPLFPLNGSHDLGIILQRIRDMPYMDPSGNNLGTAVVTAHRYMLAPDAPGRRQHVPGVMVLLVDEPLRGDIFSPIREAQASGLNVVMLGMAGADPEQLRRLAPGMDSVQTFFAVDDGPSLDQAVSGLATALCQASFTTQPRPEPCPVYCPKGQKGEPGEMGLRGQVGPPGDPGLPGRTGAPGPQGPPGSATAKGERGFPGADGRPGSPGRAGNPGTPGAPGLKGSPGLPGPRGDPGERGPRGPKGEPGAPGQVIGGEGPGLPGRKGDPGPSGPPGPRGPLGDPGPRGPPGLPGTAMKGDKGDRGERGPPGPGEGGIAPGEPGLPGLPGSPGPQGPVGPPGKKGEKGDSEDGAPGLPGQPGSPGEQGPRGPPGAIGPKGDRGFPGPLGEAGEKGERGPPGPAGSRGLPGVAGRPGAKGPEGPPGPTGRQGEKGEPGRPGDPAVVGPAVAGPKGEKGDVGPAGPRGATGVQGERGPPGLVLPGDPGPKGDPGDRGPIGLTGRAGPPGDSGPPGEKGDPGRPGPPGPVGPRGRDGEVGEKGDEGPPGDPGLPGKAGERGLRGAPGVRGPVGEKGDQGDPGEDGRNGSPGSSGPKGDRGEPGPPGPPGRLVDTGPGAREKGEPGDRGQEGPRGPKGDPGLPGAPGERGIEGFRGPPGPQGDPGVRGPAGEKGDRGPPGLDGRSGLDGKPGAAGPSGPNGAAGKAGDPGRDGLPGLRGEQGLPGPSGPPGLPGKPGEDGKPGLNGKNGEPGDPGEDGRKGEKGDSGASGREGRDGPKGERGAPGILGPQGPPGLPGPVGPPGQGFPGVPGGTGPKGDRGETGSKGEQGLPGERGLRGEPGSVPNVDRLLETAGIKASALREIVETWDESSGSFLPVPERRRGPKGDSGEQGPPGKEGPIGFPGERGLKGDRGDPGPQGPPGLALGERGPPGPSGLAGEPGKPGIPGLPGRAGGVGEAGRPGERGERGEKGERGEQGRDGPPGLPGTPGPPGPPGPKVSVDEPGPGLSGEQGPPGLKGAKGEPGSNGDQGPKGDRGVPGIKGDRGEPGPRGQDGNPGLPGERGMAGPEGKPGLQGPRGPPGPVGGHGDPGPPGAPGLAGPAGPQGPSGLKGEPGETGPPGRGLTGPTGAVGLPGPPGPSGLVGPQGSPGLPGQVGETGKPGAPGRDGASGKDGDRGSPGVPGSPGLPGPVGPKGEPGPTGAPGQAVVGLPGAKGEKGAPGGLAGDLVGEPGAKGDRGLPGPRGEKGEAGRAGEPGDPGEDGQKGAPGPKGFKGDPGVGVPGSPGPPGPPGVKGDLGLPGLPGAPGVVGFPGQTGPRGEMGQPGPSGERGLAGPPGREGIPGPLGPPGPPGSVGPPGASGLKGDKGDPGVGLPGPRGERGEPGIRGEDGRPGQEGPRGLTGPPGSRGERGEKGDVGSAGLKGDKGDSAVILGPPGPRGAKGDMGERGPRGLDGDKGPRGDNGDPGDKGSKGEPGDKGSAGLPGLRGLLGPQGQPGAAGIPGDPGSPGKDGVPGIRGEKGDVGFMGPRGLKGERGVKGACGLDGEKGDKGEAGPPGRPGLAGHKGEMGEPGVPGQSGAPGKEGLIGPKGDRGFDGQPGPKGDQGEKGERGTPGIGGFPGPSGNDGSAGPPGPPGSVGPRGPEGLQGQKGERGPPGERVVGAPGVPGAPGERGEQGRPGPAGPRGEKGEAALTEDDIRGFVRQEMSQHCACQGQFIASGSRPLPSYAADTAGSQLHAVPVLRVSHAEEEERVPPEDDEYSEYSEYSVEEYQDPEAPWDSDDPCSLPLDEGSCTAYTLRWYHRAVTGSTEACHPFVYGGCGGNANRFGTREACERRCPPRVVQSQGTGTAQD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
28DimethylationVRAQHRERVTCTRLY
HHHHHHHHCCHHHHE
29.06-
35PhosphorylationRVTCTRLYAADIVFL
HCCHHHHEECEEEEE
9.1019835603
47PhosphorylationVFLLDGSSSIGRSNF
EEEECCCCCCCCCCH
31.3519835603
117PhosphorylationLSYKGGNTRTGAAIL
HHCCCCCCCCCEEEE
32.65-
202PhosphorylationFFFVNDFSILRTLLP
EEEECHHHHHHHHHH
24.47-
278PhosphorylationGLGQPLPSERQEVNV
CCCCCCCCCCCCCCC
53.7624719451
301PhosphorylationLRGLRPLTEYQVTVI
ECCCCCCCCCEEEEE
35.0224043423
303PhosphorylationGLRPLTEYQVTVIAL
CCCCCCCCEEEEEEE
11.7524043423
311PhosphorylationQVTVIALYANSIGEA
EEEEEEEEECCHHHH
8.5024043423
314PhosphorylationVIALYANSIGEAVSG
EEEEEECCHHHHHCC
24.6524043423
320PhosphorylationNSIGEAVSGTARTTA
CCHHHHHCCCCCCCC
37.1624043423
322PhosphorylationIGEAVSGTARTTALE
HHHHHCCCCCCCCCC
12.8824043423
337N-linked_GlycosylationGPELTIQNTTAHSLL
CCCEEEECCCCCEEE
35.23UniProtKB CARBOHYD
354PhosphorylationWRSVPGATGYRVTWR
ECCCCCCCCEEEEEE
40.43-
356PhosphorylationSVPGATGYRVTWRVL
CCCCCCCEEEEEEEE
9.50-
402PhosphorylationVSTLFGRSVGPATSL
EEHHHCCCCCCCHHH
31.63-
408PhosphorylationRSVGPATSLMARTDA
CCCCCCHHHHHCCCC
20.4627251275
585PhosphorylationRVGPREGSASVLTVR
EECCCCCCCEEEEEE
16.7728464451
587PhosphorylationGPREGSASVLTVRRE
CCCCCCCEEEEEECC
21.2528464451
597PhosphorylationTVRREPETPLAVPGL
EEECCCCCCCCCCCE
34.03-
691PhosphorylationDPLGPVRTVHVTQAS
CCCCCCEEEEEEECC
18.39-
695PhosphorylationPVRTVHVTQASSSSV
CCEEEEEEECCCCCE
11.98-
703PhosphorylationQASSSSVTITWTRVP
ECCCCCEEEEEEECC
18.03-
786N-linked_GlycosylationVSRLQILNASSDVLR
EEEHHHHHCCCCEEE
39.13UniProtKB CARBOHYD
788PhosphorylationRLQILNASSDVLRIT
EHHHHHCCCCEEEEE
26.4623403867
788O-linked_GlycosylationRLQILNASSDVLRIT
EHHHHHCCCCEEEEE
26.4630059200
789PhosphorylationLQILNASSDVLRITW
HHHHHCCCCEEEEEE
29.3623403867
826PhosphorylationHQILPGNTDSAEIRG
CCCCCCCCCCHHHCC
36.9326657352
828PhosphorylationILPGNTDSAEIRGLE
CCCCCCCCHHHCCCC
26.2623312004
952PhosphorylationSAEVTARTESPRVPS
CCEEEECCCCCCCCC
38.0523403867
954PhosphorylationEVTARTESPRVPSIE
EEEECCCCCCCCCEE
19.8623403867
959PhosphorylationTESPRVPSIELRVVD
CCCCCCCCEEEEEEE
26.3223403867
988PhosphorylationRASSYILSWRPLRGP
CCCCEEEEECCCCCC
16.1024719451
1045PhosphorylationPEASVTQTPVCPRGL
CCCCCCCCCCCCCCC
14.3424719451
1062PhosphorylationVVFLPHATQDNAHRA
EEEECCCCCCHHHHH
33.1624719451
1098PhosphorylationVQVGLLSYSHRPSPL
EEEECCCCCCCCCCC
14.4122210691
1099PhosphorylationQVGLLSYSHRPSPLF
EEECCCCCCCCCCCC
15.0522210691
1109N-linked_GlycosylationPSPLFPLNGSHDLGI
CCCCCCCCCCCCHHH
50.59UniProtKB CARBOHYD
1309PhosphorylationGADGRPGSPGRAGNP
CCCCCCCCCCCCCCC
27.1928674419
1318PhosphorylationGRAGNPGTPGAPGLK
CCCCCCCCCCCCCCC
21.5826055452
1327PhosphorylationGAPGLKGSPGLPGPR
CCCCCCCCCCCCCCC
17.7626055452
1396PhosphorylationGPPGLPGTAMKGDKG
CCCCCCCCCCCCCCC
22.9528348404
1470MethylationSPGEQGPRGPPGAIG
CCCCCCCCCCCCCCC
76.66-
1686PhosphorylationGEDGRNGSPGSSGPK
CCCCCCCCCCCCCCC
29.6322817900
1690PhosphorylationRNGSPGSSGPKGDRG
CCCCCCCCCCCCCCC
66.1022817900
1918PhosphorylationPKGDRGETGSKGEQG
CCCCCCCCCCCCCCC
49.9729759185
1920PhosphorylationGDRGETGSKGEQGLP
CCCCCCCCCCCCCCC
44.9329759185
1938PhosphorylationGLRGEPGSVPNVDRL
CCCCCCCCCCCHHHH
45.1525404012
2030PhosphorylationERGPPGPSGLAGEPG
CCCCCCCCCCCCCCC
52.9728064214
2036HydroxylationPSGLAGEPGKPGIPG
CCCCCCCCCCCCCCC
56.012537292
2039HydroxylationLAGEPGKPGIPGLPG
CCCCCCCCCCCCCCC
52.432537292
2083PhosphorylationGPPGLPGTPGPPGPP
CCCCCCCCCCCCCCC
24.1128555341
2084HydroxylationPPGLPGTPGPPGPPG
CCCCCCCCCCCCCCC
60.242537292
2087HydroxylationLPGTPGPPGPPGPKV
CCCCCCCCCCCCCCC
74.062537292
2090HydroxylationTPGPPGPPGPKVSVD
CCCCCCCCCCCCCCC
77.092537292
2121PhosphorylationGAKGEPGSNGDQGPK
CCCCCCCCCCCCCCC
48.6429396449
2167HydroxylationMAGPEGKPGLQGPRG
CCCCCCCCCCCCCCC
60.632537292
2176HydroxylationLQGPRGPPGPVGGHG
CCCCCCCCCCCCCCC
63.642537292
2185HydroxylationPVGGHGDPGPPGAPG
CCCCCCCCCCCCCCC
62.882537292
2188HydroxylationGHGDPGPPGAPGLAG
CCCCCCCCCCCCCCC
58.452537292
2273PhosphorylationGKDGDRGSPGVPGSP
CCCCCCCCCCCCCCC
21.2626425664
2279PhosphorylationGSPGVPGSPGLPGPV
CCCCCCCCCCCCCCC
15.1026425664
2492MethylationRPGQEGPRGLTGPPG
CCCCCCCCCCCCCCC
64.71-
2504MethylationPPGSRGERGEKGDVG
CCCCCCCCCCCCCCC
62.49-
2512PhosphorylationGEKGDVGSAGLKGDK
CCCCCCCCCCCCCCC
21.0024719451
2625O-linked_GlycosylationFMGPRGLKGERGVKG
CCCCCCCCCCCCCCC
62.64-
2625HydroxylationFMGPRGLKGERGVKG
CCCCCCCCCCCCCCC
62.642537292
2631HydroxylationLKGERGVKGACGLDG
CCCCCCCCCCCCCCC
43.552537292
2631O-linked_GlycosylationLKGERGVKGACGLDG
CCCCCCCCCCCCCCC
43.55-
2664HydroxylationHKGEMGEPGVPGQSG
CCCCCCCCCCCCCCC
43.272537292
2667HydroxylationEMGEPGVPGQSGAPG
CCCCCCCCCCCCCCC
40.812537292
2673HydroxylationVPGQSGAPGKEGLIG
CCCCCCCCCCCCCCC
58.892537292
2682AcetylationKEGLIGPKGDRGFDG
CCCCCCCCCCCCCCC
69.138273277
2889PhosphorylationEGSCTAYTLRWYHRA
CCCEEEEEEEEHHHH
13.8424719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CO7A1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CO7A1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CO7A1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LAMA5_HUMANLAMA5physical
9245798
CO1A1_HUMANCOL1A1physical
9169408
CO4A1_HUMANCOL4A1physical
9169408
FINC_HUMANFN1physical
9169408
LAMB3_HUMANLAMB3physical
9989793
LAMC2_HUMANLAMC2physical
9989793
LRC57_HUMANLRRC57physical
22939629

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
Note=Epidermolysis bullosa acquisita (EBA) is an autoimmune acquired blistering skin disease resulting from autoantibodies to type VII collagen.
131750
226600Epidermolysis bullosa dystrophica, autosomal recessive (RDEB)
131750Epidermolysis bullosa dystrophica, Pasini type (P-DEB)
226600Epidermolysis bullosa dystrophica, Hallopeau-Siemens type (HS-DEB)
131705Transient bullous dermolysis of the newborn (TBDN)
131850Epidermolysis bullosa dystrophica, pretibial type (PR-DEB)
132000Epidermolysis bullosa dystrophica, Bart type (B-DEB)
604129Epidermolysis bullosa pruriginosa (EBP)
607523Nail disorder, non-syndromic congenital, 8 (NDNC8)
131750Epidermolysis bullosa dystrophica, with subcorneal cleavage (EBDSC)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CO7A1_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP